All trans retinoic acid (ATRA) has demonstrated curative activity in acute promyelocytic leukemia (APL), a distinct subtype of acute myeloid leukemia (AML), that is characterized by a chromosomal...

The successful development and commercialization of personalized medicines often necessitate use of companion diagnostics (CDx).

Research and development for potential COVID vaccines and treatments has been at the forefront of the pharmaceutical industry for most of 2020. Because of this, research dedicated to other...

Chief Pathologist John Cochran discusses how clinical trials offer pathologists the opportunity to work at the forefront of diagnostic discovery in this interview from The Pathologist.

To use next-generation sequencing technology such as RNA-seq for medical and health applications, choosing proper analysis methods for biomarker identification remains a critical challenge for most...

Over the past few years, there has been growth in the use of point of care (POC) testing at investigator sites in clinical trials. For example, devices have been deployed at investigator sites to...

The National Cancer Institute conducted the Biospecimen Pre-analytical Variables (BPV) study to determine the effects of formalin fixation and delay to fixation (DTF) on the analysis of nucleic...

Immune cell infiltrates within the tumor microenvironment can influence treatment response and outcome in several cancers. In this study, we developed RNA-based immune signatures from pan-cancer...

Approach to Strategy  

Our CSO Patrice Hugo recently sat with members of The Conference Forum at the Immuno-Oncology 360° 2019 conference, where he discussed immuno-oncology (IO) lab services. He shared the company's...